Literature DB >> 33543313

Polydopamine-based quantitation of albuminuria for the assessment of kidney damage.

Francesca Torrini1, Simona Scarano1, Pasquale Palladino2, Maria Minunni1.   

Abstract

Proteinuria is considered indicative of kidney damage that can be related to various adverse outcomes. Nowadays, there is a huge demand for routine urine screening methods to assess health risks in clinical setting without expensive procedures and long pretreatment of the sample. To address this issue, a polydopamine-based colorimetric assay to determine urinary albumin concentration in real samples is proposed here. The core of this approach relies on the established competitive adsorption of polydopamine film and human serum albumin onto the polystyrene surface of ELISA plates. Herein, we investigated the influence of temperature and the Tris-HCl buffer concentration on the polydopamine film growth. The absorbance of polydopamine film, after 24 h at 25 °C, decreases with the increase of HSA concentration, allowing the selective detection of HSA down to 0.036 ± 0.001 g L-1 in untreated urine. This simple and low-cost bioanalytical assay exhibited very good reproducibility, %CVmean = 2 in human urine, and was superior in terms of analytical performances to some standard methods available on the market, especially in comparison to the Bradford assay, for early screening and assessment of kidney damage.

Entities:  

Keywords:  Albuminuria; Colorimetry; Kidney disease; Polydopamine (PDA); Proteinuria; Urinalysis

Mesh:

Substances:

Year:  2021        PMID: 33543313     DOI: 10.1007/s00216-021-03192-z

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  2 in total

1.  Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.

Authors:  Shengnan Chen; Lei Chen; Hongli Jiang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

2.  Colorimetric determination of carbidopa in anti-Parkinson drugs based on 4-hydroxy-3-methoxybenzaldazine formation by reaction with vanillin.

Authors:  Mariagrazia Lettieri; Simona Scarano; Pasquale Palladino; Maria Minunni
Journal:  Anal Bioanal Chem       Date:  2022-08-04       Impact factor: 4.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.